Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

1(25.0%)

Phase 1

1(25.0%)

Phase 2

1(25.0%)

Phase 4

1(25.0%)

4Total

N/A(1)

Phase 1(1)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT05594069Not ApplicableCompleted

Effect of Triple Pre-rehabilitation on Radiotherapy for Head and Neck Cancer Patients

Role: collaborator

NCT04573049Phase 4Unknown

The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement

Role: collaborator

NCT02902432Phase 2Unknown

A Trial of Endostar in Patients With Carcinoma of the Head and Neck

Role: lead

NCT03654612Phase 1Unknown

Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies

Role: lead

All 4 trials loaded